B.Riley Lowers Price Target for Harrow, Inc. Amid Near-Term Challenges

B.Riley lowered its price target for Harrow, Inc. (NASDAQ:HROW) to $60 from $65 following weaker pricing and near-term growth expectations in Q1 2026 results. Despite this reduction, the firm maintained a Buy rating due to improving volume trends and strong demand signals across key products.

By Laiba Immad Wed, May 20, 2026 at 11:43 PM GMT+3 2 min read · Yahoo Finance · May 20, 2026, 20:43 UTC

B.Riley Lowers Price Target for Harrow, Inc. Amid Near-Term Challenges

Tickers: $HROW

Topics: pharmaceuticals price target reduction stock analysis

Read the full article at Yahoo Finance

More World news

Teekay Tankers Shares Decline Despite Q3 Earnings Beat and New Vessel Orders Seeking Alpha · November 12, 2026, 18:27 UTC
U.S. 30-Year Treasury Auction Yields Rise as Demand Weakens Seeking Alpha · November 12, 2026, 18:30 UTC
Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC
Bit Digital Reports Q3 2026 Net Income of $28.5 Million Amid Revenue Decline Motley Fool · November 12, 2026, 18:26 UTC
EZCORP Reports Strong Q4 2026 Results with Significant EBITDA and Revenue Growth Motley Fool · November 12, 2026, 18:16 UTC
Sabre Corp Shares Decline Following Travelport Denial of Merger Speculation Seeking Alpha · November 12, 2026, 18:21 UTC
Lufax Reports Third Quarter 2026 Net Loss Amid Rising Credit Impairment Costs Motley Fool · November 12, 2026, 18:15 UTC
Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026 Motley Fool · November 12, 2026, 18:15 UTC
MGP Ingredients Rebrands to Sempreon and Announces Strategic Shift Toward Ready-to-Drink Products Motley Fool · November 12, 2026, 18:15 UTC
ICON Reports Q3 2026 Revenue of $2 Billion and Accelerating Book-to-Bill Ratio Motley Fool · November 12, 2026, 18:15 UTC